Insiders / Alles Mark J
Alles Mark J
CIK 1538897personinsider
Companies
4
First seen
Feb 4, 2015
Last activity
Sep 19, 2023
Companies
| Company | Shares held | Latest |
|---|---|---|
| Celgene Corp /De/ · CELG | 111,040 | — |
| Biomarin Pharmaceutical Inc · BMRN | 15,095 | — |
| Syros Pharmaceuticals, Inc. · SYRS | 3,666 | — |
| Turning Point Therapeutics, Inc. · TPTX | 0 | — |
All securities held
6 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Biomarin Pharmaceutical Inc | Common stock | 15,095 |
| Celgene Corp /De/ | Common stock | 111,040 |
| Syros Pharmaceuticals, Inc. | Common stock | 3,666 |
Awards
| Company | Security | Shares |
|---|---|---|
| Syros Pharmaceuticals, Inc. | Restricted units | 5,334 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Celgene Corp /De/ | Options | 13,124 |
| Syros Pharmaceuticals, Inc. | Options | 6,000 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 6, 2015 | Sell Open-market sale | CELG Celgene Corp /De/ Common Stock | $14.13M | -117K -67.30% | 56,902 | medium |
| Feb 6, 2015 | Other Withheld for taxes | CELG Celgene Corp /De/ Common Stock | $1.62M | -14K -15.65% | 73,640 | low |
| Feb 6, 2015 | Exercise Option exercise | CELG Celgene Corp /De/ Common Stock | $1.23M |